The IVDR certification allows the company to pursue market expansion within Europe's in vitro diagnostic market.
Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union ...
Biomerica (BMRA) announces that its food intolerance products for Crohn’s Disease and Ulcerative Colitis have achieved CE-marking under the ...
Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the ...
IRVINE, Calif. - Biomerica, Inc. (NASDAQ:BMRA), a developer of medical diagnostic solutions, has achieved a significant regulatory milestone with the CE marking of its food intolerance products ...
Biomerica, Inc. has achieved IVDR certification for its food intolerance products designed for managing Crohn's Disease and Ulcerative Colitis, marking a significant step in compliance with ...
The tests identify specific foods that may trigger inflammation in patients with Crohn's disease and ulcerative colitis.